Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation

Safety, Efficacy, and Outcomes of N-Butyl Cyanoacrylate Glue Injection through the Endoscopic or Radiologic Route for Variceal Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis

We performed a systematic review and meta-analysis of published studies to assess the efficacy, safety, and outcomes of N-butyl cyanoacrylate (NBCA) injection for the treatment of variceal gastrointestinal bleeding (GIB). The MEDLINE/PubMed, EMBASE, and SCOPUS databases were searched for English-language studies published from January 1980 to December 2019 and including patients who had injection of NBCA for variceal GIB. Two independent reviewers extracted and evaluated the data from eligible studies. Exclusion criteria were sample size < 5, article reporting the use of NBCA with other embolic agents, no extractable data, and duplicate reports. NBCA was injected during endoscopy in 42 studies and through a direct percutaneous approach for stomal varices in 1 study. The study’s endpoints were: Technical success, 30-day rebleeding, and 30-day overall and major complications. The estimated overall rates were computed with 95% confidence intervals, based on each study rate, weighted by the number of patients involved in each study. In total, 43 studies with 3484 patients were included. The technical success rate was 94.1% (95% CI: 91.6–96.1%), the 30-day rebleeding rate was 24.2% (18.9–29.9%), and 30-day overall and major complications occurred in 15.9% (11.2–21.3%) and 5.3% (3.3–7.8%) of patients, respectively. For treating variceal GIB, NBCA injection is a safe and effective method that demonstrates high technical success rate and very low major complication rate.

Metal artifact reduction using mono-energy images combined with metal artifact reduction software in spectral computed tomography: a study on phantoms

BACKGROUND

This study aimed to evaluate the effectiveness of spectral computed tomography (CT) mono-energy imaging combined with metal artifact reduction software (MARs) for metal implant artifact reduction using a phantom.

METHODS

A quantitative standard phantom with 9 cylinders was used to simulate the attenuation of the different tissues of the human body around the metal implant. Groups A and B were divided according to conventional CT scan mode and spectral CT scan mode. Three sets of reconstructed images, including 120 kVp-like + MARs images, mono-energy images (MonoE), and MonoE + MARs images, were generated after spectral CT scanning. High-attenuation artifacts and low-attenuation artifacts were observed around the coil in the images of groups A and B. The CT values (Hounsfield unit) and standard deviation (SD) values of the artifacts were measured, and the artifact index and hardening artifact removal rate were calculated.

RESULTS

Compared to conventional poly-energy CT images, for high-attenuation and low-attenuation artifacts, the artifact indices of 120 kVp-like + MARs, MonoE, and MonoE + MARs images were all reduced significantly. The hardening artifact removal rates of the high-attenuation and low-attenuation artifacts of 120 kVp-like + MARs images were 82% and 92%, respectively. The hardening artifact removal rate of the high-attenuation and low-attenuation artifacts of MonoE and MonoE + MARs images increased with the mono-energy level.

CONCLUSIONS

Spectral CT using the 120 kVp-like + MARs, 110-140 keV MonoE, and MonoE + MARs reconstruction methods can reduce metal implant artifacts in varying degrees. MonoE + MARs reconstruction was the best method for reducing metal artifacts.